Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

CCR Translations

  • CCR Translations
    Expanding the Use of Retinoids in Acute Myeloid Leukemia: Spotlight on Bexarotene
    Suzan McNamara and Wilson H. Miller Jr.
    Clin Cancer Res September 1 2008 14 (17) 5311-5313; DOI:10.1158/1078-0432.CCR-08-1081

Molecular Pathways

  • Molecular Pathways
    Oncogenic NOTCH1 Control of MYC and PI3K: Challenges and Opportunities for Anti-NOTCH1 Therapy in T-Cell Acute Lymphoblastic Leukemias and Lymphomas
    Teresa Palomero and Adolfo Ferrando
    Clin Cancer Res September 1 2008 14 (17) 5314-5317; DOI:10.1158/1078-0432.CCR-07-4864

  • Molecular Pathways
    Targeting the MDM2-p53 Interaction for Cancer Therapy
    Sanjeev Shangary and Shaomeng Wang
    Clin Cancer Res September 1 2008 14 (17) 5318-5324; DOI:10.1158/1078-0432.CCR-07-5136

Report from the FDA

  • Report from the FDA
    Tasigna for Chronic and Accelerated Phase Philadelphia Chromosome–Positive Chronic Myelogenous Leukemia Resistant to or Intolerant of Imatinib
    Maitreyee Hazarika, Xiaoping Jiang, Qi Liu, Shwu-Luan Lee, Roshni Ramchandani, Christine Garnett, Micheal S. Orr, Rajeshwari Sridhara, Brian Booth, John K. Leighton, William Timmer, Ravi Harapanhalli, Ramzi Dagher, Robert Justice and Richard Pazdur
    Clin Cancer Res September 1 2008 14 (17) 5325-5331; DOI:10.1158/1078-0432.CCR-08-0308

Human Cancer Biology

  • Human Cancer Biology
    Expanding the Roles for Pregnane X Receptor in Cancer: Proliferation and Drug Resistance in Ovarian Cancer
    Divya Gupta, Madhukumar Venkatesh, Hongwei Wang, Sean Kim, Michael Sinz, Gary L. Goldberg, Kathleen Whitney, Clifford Longley and Sridhar Mani
    Clin Cancer Res September 1 2008 14 (17) 5332-5340; DOI:10.1158/1078-0432.CCR-08-1033

  • Human Cancer Biology
    β2-Microglobulin Signaling Blockade Inhibited Androgen Receptor Axis and Caused Apoptosis in Human Prostate Cancer Cells
    Wen-Chin Huang, Jonathan J. Havel, Haiyen E. Zhau, Wei Ping Qian, Hui-Wen Lue, Chia-Yi Chu, Takeo Nomura and Leland W.K. Chung
    Clin Cancer Res September 1 2008 14 (17) 5341-5347; DOI:10.1158/1078-0432.CCR-08-0793

  • Human Cancer Biology
    Expression and Gene Amplification of Actinin-4 in Invasive Ductal Carcinoma of the Pancreas
    Satoru Kikuchi, Kazufumi Honda, Hitoshi Tsuda, Nobuyoshi Hiraoka, Issei Imoto, Tomoo Kosuge, Tomoko Umaki, Kaoru Onozato, Miki Shitashige, Umio Yamaguchi, Masaya Ono, Akihiko Tsuchida, Tatsuya Aoki, Johji Inazawa, Setsuo Hirohashi and Tesshi Yamada
    Clin Cancer Res September 1 2008 14 (17) 5348-5356; DOI:10.1158/1078-0432.CCR-08-0075

  • Human Cancer Biology
    Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression
    Celina G. Kleer, Noga Bloushtain-Qimron, Yu-Hui Chen, Daniel Carrasco, Min Hu, Jun Yao, Stine-Kathrein Kraeft, Laura C. Collins, Michael S. Sabel, Pedram Argani, Rebecca Gelman, Stuart J. Schnitt, Ian E. Krop and Kornelia Polyak
    Clin Cancer Res September 1 2008 14 (17) 5357-5367; DOI:10.1158/1078-0432.CCR-08-0732

  • Human Cancer Biology
    Induction of Receptor for Advanced Glycation End Products by EBV Latent Membrane Protein 1 and Its Correlation with Angiogenesis and Cervical Lymph Node Metastasis in Nasopharyngeal Carcinoma
    Akira Tsuji, Naohiro Wakisaka, Satoru Kondo, Shigeyuki Murono, Mitsuru Furukawa and Tomokazu Yoshizaki
    Clin Cancer Res September 1 2008 14 (17) 5368-5375; DOI:10.1158/1078-0432.CCR-08-0198

  • Human Cancer Biology
    Overexpression of the Zinc Uptake Transporter hZIP1 Inhibits Nuclear Factor-κB and Reduces the Malignant Potential of Prostate Cancer Cells In vitro and In vivo
    Konstantin Golovine, Peter Makhov, Robert G. Uzzo, Tavis Shaw, David Kunkle and Vladimir M. Kolenko
    Clin Cancer Res September 1 2008 14 (17) 5376-5384; DOI:10.1158/1078-0432.CCR-08-0455

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation
    Guo Zhang, Margaret A. Park, Clint Mitchell, Hossein Hamed, Mohamed Rahmani, Aditi Pandya Martin, David T. Curiel, Adly Yacoub, Martin Graf, Ray Lee, John D. Roberts, Paul B. Fisher, Steven Grant and Paul Dent
    Clin Cancer Res September 1 2008 14 (17) 5385-5399; DOI:10.1158/1078-0432.CCR-08-0469

  • Cancer Therapy: Preclinical
    Oncostatin M Induces Bone Loss and Sensitizes Rat Osteosarcoma to the Antitumor Effect of Midostaurin In vivo
    Bénédicte Brounais, Céline Chipoy, Kanji Mori, Céline Charrier, Séverine Battaglia, Paul Pilet, Carl D. Richards, Dominique Heymann, Françoise Rédini and Frédéric Blanchard
    Clin Cancer Res September 1 2008 14 (17) 5400-5409; DOI:10.1158/1078-0432.CCR-07-4781

  • Cancer Therapy: Preclinical
    Postradiation Sensitization of the Histone Deacetylase Inhibitor Valproic Acid
    Prakash Chinnaiyan, David Cerna, William E. Burgan, Katie Beam, Eli S. Williams, Kevin Camphausen and Philip J. Tofilon
    Clin Cancer Res September 1 2008 14 (17) 5410-5415; DOI:10.1158/1078-0432.CCR-08-0643

  • Cancer Therapy: Preclinical
    Inhibition of the p53 E3 Ligase HDM-2 Induces Apoptosis and DNA Damage–Independent p53 Phosphorylation in Mantle Cell Lymphoma
    Richard J. Jones, Qing Chen, Peter M. Voorhees, Ken H. Young, Nathalie Bruey-Sedano, Dajun Yang and Robert Z. Orlowski
    Clin Cancer Res September 1 2008 14 (17) 5416-5425; DOI:10.1158/1078-0432.CCR-08-0150

  • Cancer Therapy: Preclinical
    Matuzumab Short-Term Therapy in Experimental Pancreatic Cancer: Prolonged Antitumor Activity in Combination with Gemcitabine
    Axel Kleespies, Ivan Ischenko, Martin E. Eichhorn, Hendrik Seeliger, Christiane Amendt, Ole Mantell, Karl-Walter Jauch and Christiane J. Bruns
    Clin Cancer Res September 1 2008 14 (17) 5426-5436; DOI:10.1158/1078-0432.CCR-07-5245

  • Cancer Therapy: Preclinical
    Targeting Aurora Kinase with MK-0457 Inhibits Ovarian Cancer Growth
    Yvonne G. Lin, Anand Immaneni, William M. Merritt, Lingegowda S. Mangala, Seung Wook Kim, Mian M.K. Shahzad, Yvonne T.M. Tsang, Guillermo N. Armaiz-Pena, Chunhua Lu, Aparna A. Kamat, Liz Y. Han, Whitney A. Spannuth, Alpa M. Nick, Charles N. Landen Jr., Kwong K. Wong, Michael J. Gray, Robert L. Coleman, Diane C. Bodurka, William R. Brinkley and Anil K. Sood
    Clin Cancer Res September 1 2008 14 (17) 5437-5446; DOI:10.1158/1078-0432.CCR-07-4922

  • Cancer Therapy: Preclinical
    Inhibition of Glioblastoma Growth in a Highly Invasive Nude Mouse Model Can Be Achieved by Targeting Epidermal Growth Factor Receptor but not Vascular Endothelial Growth Factor Receptor-2
    Tobias Martens, Yvonne Laabs, Hauke S. Günther, Dirk Kemming, Zhenping Zhu, Larry Witte, Christian Hagel, Manfred Westphal and Katrin Lamszus
    Clin Cancer Res September 1 2008 14 (17) 5447-5458; DOI:10.1158/1078-0432.CCR-08-0147

  • Cancer Therapy: Preclinical
    Multi-Kinase Inhibitor E7080 Suppresses Lymph Node and Lung Metastases of Human Mammary Breast Tumor MDA-MB-231 via Inhibition of Vascular Endothelial Growth Factor-Receptor (VEGF-R) 2 and VEGF-R3 Kinase
    Junji Matsui, Yasuhiro Funahashi, Toshimitsu Uenaka, Tatsuo Watanabe, Akihiko Tsuruoka and Makoto Asada
    Clin Cancer Res September 1 2008 14 (17) 5459-5465; DOI:10.1158/1078-0432.CCR-07-5270

  • Cancer Therapy: Preclinical
    Combined Vascular Endothelial Growth Factor Receptor/Epidermal Growth Factor Receptor Blockade with Chemotherapy for Treatment of Local, Uterine, and Metastatic Soft Tissue Sarcoma
    Wenhong Ren, Borys Korchin, Guy Lahat, Caimiao Wei, Svetlana Bolshakov, Theresa Nguyen, William Merritt, Adam Dicker, Alexander Lazar, Anil Sood, Raphael E. Pollock and Dina Lev
    Clin Cancer Res September 1 2008 14 (17) 5466-5475; DOI:10.1158/1078-0432.CCR-08-0562

  • Cancer Therapy: Preclinical
    Thymidine Selectively Enhances Growth Suppressive Effects of Camptothecin/Irinotecan in MSI+ Cells and Tumors Containing a Mutation of MRE11
    Rene Rodriguez, Lasse Tengbjerg Hansen, Geraldine Phear, Jennifer Scorah, Mogens Spang-Thomsen, Angela Cox, Thomas Helleday and Mark Meuth
    Clin Cancer Res September 1 2008 14 (17) 5476-5483; DOI:10.1158/1078-0432.CCR-08-0274

  • Cancer Therapy: Preclinical
    Effective CpG Immunotherapy of Breast Carcinoma Prevents but Fails to Eradicate Established Brain Metastasis
    Zhengming Xiong, Soheila Gharagozlou, Isabelita Vengco, Wei Chen and John R. Ohlfest
    Clin Cancer Res September 1 2008 14 (17) 5484-5493; DOI:10.1158/1078-0432.CCR-07-4139

  • Cancer Therapy: Preclinical
    TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis
    Wanhua Yang, Danfeng Luo, Shixuan Wang, Rui Wang, Rui Chen, Yan Liu, Tao Zhu, Xiangyi Ma, Ronghua Liu, Gang Xu, Li Meng, Yunping Lu, Jianfeng Zhou and Ding Ma
    Clin Cancer Res September 1 2008 14 (17) 5494-5502; DOI:10.1158/1078-0432.CCR-08-0233

  • Cancer Therapy: Preclinical
    Matrilysin (MMP-7) Is a Novel Broadly Expressed Tumor Antigen Recognized by Antigen-Specific T Cells
    Yuko Yokoyama, Frank Grünebach, Susanne M. Schmidt, Annkristin Heine, Maik Häntschel, Stefan Stevanovic, Hans-Georg Rammensee and Peter Brossart
    Clin Cancer Res September 1 2008 14 (17) 5503-5511; DOI:10.1158/1078-0432.CCR-07-4041

  • Cancer Therapy: Preclinical
    Eradication of Ovarian Tumor Xenografts by Locoregional Administration of Targeted Immunotherapy
    Michelandrea De Cesare, Claudia Calcaterra, Graziella Pratesi, Laura Gatti, Franco Zunino, Sylvie Mènard and Andrea Balsari
    Clin Cancer Res September 1 2008 14 (17) 5512-5518; DOI:10.1158/1078-0432.CCR-08-0445

  • Cancer Therapy: Preclinical
    Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action
    Junmei Hou, Disong Wang, Ruiwen Zhang and Hui Wang
    Clin Cancer Res September 1 2008 14 (17) 5519-5530; DOI:10.1158/1078-0432.CCR-08-0197

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Genetic Clustering of Clear Cell Renal Cell Carcinoma Based on Array-Comparative Genomic Hybridization: Its Association with DNA Methylation Alteration and Patient Outcome
    Eri Arai, Saori Ushijima, Hitoshi Tsuda, Hiroyuki Fujimoto, Fumie Hosoda, Tatsuhiro Shibata, Tadashi Kondo, Issei Imoto, Johji Inazawa, Setsuo Hirohashi and Yae Kanai
    Clin Cancer Res September 1 2008 14 (17) 5531-5539; DOI:10.1158/1078-0432.CCR-08-0443

  • Imaging, Diagnosis, Prognosis
    Whole Chromosome Alterations Predict Survival in High-Risk Neuroblastoma without MYCN Amplification
    Sven Bilke, Qing-Rong Chen, Jun S. Wei and Javed Khan
    Clin Cancer Res September 1 2008 14 (17) 5540-5547; DOI:10.1158/1078-0432.CCR-07-4461

  • Imaging, Diagnosis, Prognosis
    Magnetic Resonance Imaging–Measured Blood Flow Change after Antiangiogenic Therapy with PTK787/ZK 222584 Correlates with Clinical Outcome in Metastatic Renal Cell Carcinoma
    Cedric de Bazelaire, David C. Alsop, Daniel George, Ivan Pedrosa, Yongyu Wang, M. Dror Michaelson and Neil M. Rofsky
    Clin Cancer Res September 1 2008 14 (17) 5548-5554; DOI:10.1158/1078-0432.CCR-08-0417

  • Imaging, Diagnosis, Prognosis
    Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response
    Jozien Helleman, Maurice P.H.M. Jansen, Kirsten Ruigrok-Ritstier, Iris L. van Staveren, Maxime P. Look, Marion E. Meijer-van Gelder, Anieta M. Sieuwerts, Jan G.M. Klijn, Stefan Sleijfer, John A. Foekens and Els M.J.J. Berns
    Clin Cancer Res September 1 2008 14 (17) 5555-5564; DOI:10.1158/1078-0432.CCR-08-0555

  • Imaging, Diagnosis, Prognosis
    A Multigene Assay Is Prognostic of Survival in Patients with Early-Stage Lung Adenocarcinoma
    Dan J. Raz, M. Roshni Ray, Jae Y. Kim, Biao He, Miquel Taron, Marcin Skrzypski, Mark Segal, David R. Gandara, Rafael Rosell and David M. Jablons
    Clin Cancer Res September 1 2008 14 (17) 5565-5570; DOI:10.1158/1078-0432.CCR-08-0544

  • Imaging, Diagnosis, Prognosis
    Molecular Diagnosis of Sentinel Lymph Node Metastases in Cervical Cancer Using Squamous Cell Carcinoma Antigen
    Song-Hua Yuan, Xue-Fang Liang, Wei-Hua Jia, Jian-Ling Huang, Mei Wei, Ling Deng, Li-Zhi Liang, Xiao-Yun Wang and Yi-Xin Zeng
    Clin Cancer Res September 1 2008 14 (17) 5571-5578; DOI:10.1158/1078-0432.CCR-08-0346

  • Imaging, Diagnosis, Prognosis
    Combination of Quantitative IMP3 and Tumor Stage: A New System to Predict Metastasis for Patients with Localized Renal Cell Carcinomas
    Zhong Jiang, Peigou G. Chu, Bruce A. Woda, Qin Liu, K.C. Balaji, Kenneth L. Rock and Chin-Lee Wu
    Clin Cancer Res September 1 2008 14 (17) 5579-5584; DOI:10.1158/1078-0432.CCR-08-0504

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    Gemtuzumab Ozogamicin as Part of Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed Acute Myeloid Leukemia
    Martin Bornhäuser, Thomas Illmer, Uta Oelschlaegel, Johannes Schetelig, Rainer Ordemann, Markus Schaich, Mathias Hänel, Ulrich Schuler, Christian Thiede, Alexander Kiani, Uwe Platzbecker and Gerhard Ehninger
    Clin Cancer Res September 1 2008 14 (17) 5585-5593; DOI:10.1158/1078-0432.CCR-08-0894

  • Cancer Therapy: Clinical
    ABCB1 (MDR 1) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy
    Sharon E. Johnatty, Jonathan Beesley, Jim Paul, Sian Fereday, Amanda B. Spurdle, Penelope M. Webb, Karen Byth, Sharon Marsh, Howard McLeod, AOCS Study Group, Paul R. Harnett, Robert Brown, Anna deFazio and Georgia Chenevix-Trench
    Clin Cancer Res September 1 2008 14 (17) 5594-5601; DOI:10.1158/1078-0432.CCR-08-0606

  • Cancer Therapy: Clinical
    A Phase I Study of EKB-569 in Combination with Capecitabine in Patients with Advanced Colorectal Cancer
    Dan Laheru, Gary Croghan, Ronald Bukowski, Michelle Rudek, Wells Messersmith, Charles Erlichman, Robert Pelley, Antonio Jimeno, Ross Donehower, Joseph Boni, Richat Abbas, Patricia Martins, Charles Zacharchuk and Manuel Hidalgo
    Clin Cancer Res September 1 2008 14 (17) 5602-5609; DOI:10.1158/1078-0432.CCR-08-0433

  • Cancer Therapy: Clinical
    Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines
    Franz O. Smith, Stephanie G. Downey, Jacob A. Klapper, James C. Yang, Richard M. Sherry, Richard E. Royal, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Catherine L. Levy, Donald E. White, Seth M. Steinberg and Steven A. Rosenberg
    Clin Cancer Res September 1 2008 14 (17) 5610-5618; DOI:10.1158/1078-0432.CCR-08-0116

  • Cancer Therapy: Clinical
    A Phase I Study of Bexarotene, a Retinoic X Receptor Agonist, in Non-M3 Acute Myeloid Leukemia
    Donald E. Tsai, Selina M. Luger, Charalambos Andreadis, Dan T. Vogl, Allison Kemner, Melissa Potuzak, Ami Goradia, Alison W. Loren, Alexander E. Perl, Stephen J. Schuster, David L. Porter, Edward A. Stadtmauer, Steven C. Goldstein, James E. Thompson, Cezary Swider, Adam Bagg, Anthony R. Mato and Martin Carroll
    Clin Cancer Res September 1 2008 14 (17) 5619-5625; DOI:10.1158/1078-0432.CCR-07-5185

  • Cancer Therapy: Clinical
    CpG Oligodeoxynucleotides Alter Lymphocyte and Dendritic Cell Trafficking in Humans
    W. Nicholas Haining, Jeffrey Davies, Holger Kanzler, Linda Drury, Thomas Brenn, John Evans, Jill Angelosanto, Steven Rivoli, Kate Russell, Suzanne George, Paul Sims, Donna Neuberg, Xiaochun Li, Jeffrey Kutok, Jeffrey Morgan, Patrick Wen, George Demetri, Robert L. Coffman and Lee M. Nadler
    Clin Cancer Res September 1 2008 14 (17) 5626-5634; DOI:10.1158/1078-0432.CCR-08-0526

Cancer Prevention and Susceptibility

  • Cancer Prevention and Susceptibility
    Effect of Genetic Variability within 8q24 on Aggressiveness Patterns at Diagnosis and Familial Status of Prostate Cancer
    Olivier Cussenot, Abdel-Rahmène Azzouzi, Gladys Bantsimba-Malanda, Cecile Gaffory, Philippe Mangin, Luc Cormier, Georges Fournier, Antoine Valeri, Lionel Jouffe, Morgan Roupret, Gaelle Fromont, Mathilde Sibony, Eva Comperat and Géraldine Cancel-Tassin
    Clin Cancer Res September 1 2008 14 (17) 5635-5639; DOI:10.1158/1078-0432.CCR-07-4999

Letters to the Editor

  • Letters to the Editor
    IMP3: A New and Important Biomarker of Systemic Malignancies
    Shailendra Kapoor
    Clin Cancer Res September 1 2008 14 (17) 5640-5640; DOI:10.1158/1078-0432.CCR-08-0813

  • Letters to the Editor
    Reply to the Letter to the Editor from S. Kapoor
    Zhong Jiang
    Clin Cancer Res September 1 2008 14 (17) 5640-5640; DOI:10.1158/1078-0432.CCR-08-1236

Back to top
PreviousNext
Clinical Cancer Research: 14 (17)
September 2008
Volume 14, Issue 17
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • Targeting the MDM2-p53 Interaction for Cancer Therapy
  • Expanding the Roles for Pregnane X Receptor in Cancer: Proliferation and Drug Resistance in Ovarian Cancer
  • ABCB1 (MDR 1) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy
  • TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis

Jump to

  • CCR Translations
  • Molecular Pathways
  • Report from the FDA
  • Human Cancer Biology
  • Cancer Therapy: Preclinical
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Cancer Prevention and Susceptibility
  • Letters to the Editor
Advertisement
  • Most Cited
  • Most Read
Loading
  • FLASH-RT Spares Lung Progenitor Cells
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
  • scRNA-seq Analysis of Gastric Cancer TME
  • PDAC and GATA6 Expression
  • AR Gene Rearrangements in Prostate Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement